ACPA

Discontinued Product

1318 has been discontinued.

View all CB<sub>1</sub> Receptors products.
Description: Potent and selective CB1 agonist
Alternative Names: Arachidonylcyclopropylamide
Chemical Name: N-(Cyclopropyl)-5Z,8Z,11Z,14Z-eicosatetraenamide
Datasheet
Citations (11)
Reviews
Literature (2)

Biological Activity for ACPA

Potent and selective CB1 agonist (Ki = 2.2 nM). Displays 325-fold selectivity over CB2 receptors. Active in vivo.

Water Soluble Emulsion also available.

Technical Data for ACPA

M. Wt 343.55
Formula C23H37NO
Storage Store at -20°C
CAS Number 229021-64-1
PubChem ID 5311007
InChI Key GLGAUBPACOBAMV-DOFZRALJSA-N
Smiles O=C(NC1CC1)CCC\C=C/C\C=C/C/C=C\C/C=C\CCCCC

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for ACPA

Certificate of Analysis / Product Datasheet
Select another batch:

References for ACPA

References are publications that support the biological activity of the product.

Hillard et al (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J.Pharmacol.Exp.Ther. 289 1427 PMID: 10336536

Pertwee (1999) Pharmacology of cannabinoid receptor ligands. Curr.Med.Chem. 6 635 PMID: 10469884

Patel et al (2001) Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice. 2001 Symposium on the Cannabinoids, International

View Related Products by Target

View Related Products by Product Action

View all CB1 Receptor Agonists

Keywords: ACPA, ACPA supplier, Potent, selective, CB1, agonists, Cannabinoids, Receptors, cb1r, Arachidonylcyclopropylamide, 1318, Tocris Bioscience

11 Citations for ACPA

Citations are publications that use Tocris products. Selected citations for ACPA include:

Akerman et al (2013) Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. J Neurosci 33 14869 PMID: 24027286

Buznikov et al (2010) A putative 'pre-nervous' endocannabinoid system in early echinoderm development. Dev Neurosci 32 1 PMID: 19907129

Kangarlu-Haghighi et al (2015) The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA. Br J Pharmacol 14 613 PMID: 26648818

Niu et al (2012) Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats. EXCLI J 153 2283 PMID: 22940464


Reviews for ACPA

There are currently no reviews for this product. Be the first to review ACPA and earn rewards!

Have you used ACPA?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cannabinoid Receptor Ligands Scientific Review

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.